Ovarian carcinogenesis: Recent and past hypotheses;La cancérogense ovarienne : Théories actuelles et passées

Gynecologie Obstetrique et Fertilite

Volumn 39, Issue 4, 2011, Pages 216-223

  Chene G ^a,b   Penault Llorca, F ^a   Raoelfils, I ^a   Bignon, Y J ^b   Ray Coquard, I ^c   Seffert, P ^a   Dauplat, J ^a  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

BRCA mutation; Incessant ovulation; Ovarian carcinogenesis; Ovarian dysplasia; p53; Prophylactic oophorectomy

Indexed keywords

ARTICLE; CARCINOGENESIS; EPITHELIUM; GENETIC ANALYSIS; HUMAN; MALIGNANT TRANSFORMATION; OVARIAN CARCINOGENESIS; SIGNAL TRANSDUCTION; UTERINE TUBE; CELL TRANSFORMATION; FEMALE; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; REVIEW;

CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 79954414635     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2011.02.010     Document Type: Article

References (83)

1. J. Dauplat, and J.P. Guastalla Cancer de l'ovaire 1996 Arnette Blackwell Paris
2. M.A. Brewer, K. Johnson, M. Follen, D. Gershenson, and R.J. Bast Prevention of ovarian cancer: intra-epithelial neoplasia Clin Cancer Res 9 2003 20 30 (Pubitemid 36113233)
3. J. Dauplat, J.P. Lefranc, and A. Bremond Prevention of ovarian cancer by prophylactic ovariectomy Chirurgie 123 1998 405 440
4. Bignon YJ, Vaurs C, Vidal V. Prédispositions héré ditaires aux cancers des ovaries. In Cancer de l'ovaire. Paris; Arnette Blackwell; 1996. p. 63-5
5. D. Ford, D.F. Easton, T. Bishop, S.A. Narod, and D.E. Goldgar Risk of cancer in BRCA 1 mutation carriers Lancet 343 1994 692 695 (Pubitemid 24087847)
6. H.T. Lynch, C. Bewtra, and J.F. Lynch Familial ovarian carcinoma Am J Med 81 1986 1073 1076
7. C. Bewtra, P. Watson, T.A. Conway, C. Read-Hippee, and H.T. Lynch Hereditary ovarian cancer: A clinicopathological study Int J Gynecol Pathol 11 1992 180 187
8. D. Ford, D.F. Easton, M. Stratton, S. Narod, D. Golgar, and P. Devilee Genetic heterogeneity and penetrance analysis of the BRCA 1 and BRCA 2 genes in breast cancer families. The breast Cancer Linkage Consortium Am J Hum Genet 62 1998 676 689 (Pubitemid 28164626)
9. S.J. Ramus, and S.A. Gayther The contribution of BRCA 1 and BRCA 2 to ovarian cancer Mol Oncol 3 2009 138 150
10. A.A. Jazaeri, C.J. Yee, C. Sotiriou, K.R. Brantley, J. Boyd, and E.T. Liu Gene expression profiles of BRCA 1-linked, BRCA 2-linked, and sporadic ovarian cancers J Natl Cancer Inst 94 2002 990 1000 (Pubitemid 34814728)
11. D.T. Bishop BRCA 1, BRCA 2, BRCA 3: A myriad of breast cancer genes Eur J Cancer 30 1994 1738 1739 (Pubitemid 24377141)
12. V. Bonadona, and C. Lasset Inherited predisposition to breast cancer: after the BRCA 1 and BRCA 2 genes, what next? Bull Cancer 90 2003 587 594 (Pubitemid 37033796)
13. S. Salvador, A. Rempel, R.A. Soslow, B. Gilks, D. Huntsman, and D. Miller Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma Gynecol oncol 110 2008 408 417
14. A.A. Jazaeri Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease Mol Oncol 3 2009 151 156
15. P.A. Fasdhing, S. Gayther, L. Pearce, J.M. Schildkraut, E. Goode, and F. Thiel Role of genetic polymorphisms and ovarian cancer susceptibility Mol Oncol 3 2009 171 181
16. H.T. Lynch, M.J. Casey, C.L. Snyder, C. Bewtra, J.F. Lynch, and M. Butts Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management Mol Oncol 3 2009 97 137
17. S.D. Merajver, T.M. Pham, and R.F. Caduff Somatic mutation in the BRCA 1 gene in sporadic ovarian tumours Nat Genet 9 1995 439 443
18. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA 1 and BRCA 2 carriers Gyn Oncol 100 2006 58 64 (Pubitemid 41815050)
19. W. Zheng, J.J. Lu, F. Luo, J. Hsieh, C.Y. Wang, and C. Zhang Reduction of BRCA 1 expression in sporadic ovarian cancer Gynecol Oncol 76 2000 294 300 (Pubitemid 30131496)
20. C.A. Wilson, L. Ramos, M.R. Villasenor, K.H. Anders, M.F. Press, and K. Clarke Localization of human BRCA 1 and its loss in high-grade, non-inherited breast carcinomas Nat Genet 21 1999 236 240 (Pubitemid 29070375)
21. R.L. Baldwin, E. Nemeth, H. Tran, H. Shvartsman, I. Cass, and S. Narod BRCA 1 promoter region hyper-methylation in ovarian carcinoma: A population-based study Cancer Res 60 2000 5329 5333
22. M. Esteller, J.M. Silva, G. Dominguez, F. Bonilla, X. Matias-Guiu, and E. Lerma Promoter hyper-methylation and BRCA 1 inactivation in sporadic breast and ovarian tumours J Natl Cancer Inst 92 2000 564 569 (Pubitemid 30212318)
23. J.L. Hilton, J.P. Geisler, J.A. Rathe, M.A. Hatterman-Zogg, B. De Young, and R.E. Buller Inactivation of BRCA 1 and BRCA 2 in ovarian cancer J Natl Cancer Inst 94 2002 1396 1406
24. L.M. Bennett, K.A. McAllister, J. Malphurs, T. Ward, and R.W. Wiseman Mice heterozygous for a BRCA 1 or BRCA 2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol Cancer Res 60 2000 3461 3469 (Pubitemid 30482165)
25. G. Chene, F. Penault-Llorca, G. Le Bouedec, F. Mishellany, M.M. Dauplat, and A.S. Tardieu Ovarian epithelial dysplasia: myth or reality? Review Gynecol Obstet Fertil 36 2008 800 807
26. M. Fathalla Incessant ovulation: A factor in ovarian neoplasia? Lancet 2 1971 163
27. T. Riman, S. Nilsson, and I.R. Persson Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies Acta Obstet Gynecol Scand 83 2004 783 795 (Pubitemid 39179432)
28. D.M. Purdie, C.J. Bain, V. Siskind, P.M. Webb, and A.C. Green Ovulation and risk of epithelial ovarian cancer Int J Cancer 104 2003 228 232 (Pubitemid 36249799)
29. T. Fredrickson Ovarian tumours of the hen Environ Health Perspect 73 1987 35 51
30. Hamilton TC, Godwin AK, Ozols RF. Carcinogense ovarienne. In Cancer de l'ovaire. Paris; Arnette Blackwell; 1996. p. 21-38.
31. P.N. Bamford, and S.J. Steele Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report Br J Obstet Gynaecol. 89 1982 962 964 (Pubitemid 12007012)
32. A.S. Whittemore, R. Harris, and J. Itnyre Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women Am J Epidemiol 136 1992 1184 1203 (Pubitemid 23026890)
33. M.A. Rossing, J.R. Daling, N.S. Weiss, D.E. Moore, and S.G. Self Ovarian tumours in a cohort of infertile women N Engl J Med 331 1994 771 776 (Pubitemid 24284766)
34. J.J. Nieto, J. Crow, M. Sundaresan, N. Constantinovici, C.W. Perret, and A.N. Mc Lean Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity Gynecol Oncol 82 2001 344 349 (Pubitemid 32730615)
35. G. Chene, F. Penault-Llorca, G. Le Bouedec, F. Mishellany, M.M. Dauplat, and P. Jaffeux Ovarian epithelial dysplasia after ovulation induction: time and dose effect Human Reprod 24 2009 132 138
36. J. Dauplat, G. Chene, C. Pomel, M.M. Dauplat, G. Le Bouedec, and F. Mishellany Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer Eur J Cancer 45 2009 2977 2983
37. A. Mahdavi, T. Pejovic, and F. Nezhat Induction of ovulation and ovarian cancer: A critical review of the literature Fertil Steril 85 2006 819 826
38. A.W. Schuetz, and C. Lessman Evidence for follicle wall involvement in ovulation and progesterone production by grog follicles in vitro Differentiation 22 1982 79 84 (Pubitemid 12021371)
39. D.C. Colgin, and W.J. Murdoch Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: secretion of urokinase-type plasminogen activator Anim Reprod Sci 47 1997 197 204 (Pubitemid 27362925)
40. J.A. Hall, E.M. Meisterling, A.M. Benoit, D.A. Cooper, D.A. Coleman, and S.P. Lerner Factors contributing to the formation of experimentally induced ovarian cysts in prepubertal gilts Domest Anim Endocrinol 10 1993 141 155
41. H.O. Osterholzer, J.H. Johnson, and S.V. Nicosia An autoradiographic study of rabbit ovarian surface epithelium before and after ovulation Biol Reprod 33 1985 729 738 (Pubitemid 15247604)
42. W.J. Murdoch, and A.C. McDonnel Roles of the ovarian surface epithelium in ovulation and carcinogenesis Reproduction 123 2002 743 750 (Pubitemid 34662050)
43. A. Smokovitis, N. Kokolis, and E. Alexaki-Tzivanidou The plasminogen activator activity is marked increased mainly at the area of the rupture of the follicular wall at the time of ovulation Anim Reprod Sci 16 1988 285 294
44. X.R. Peng, A.J.W. Hsueh, and T. Ny Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation Eur J Biochem 214 1993 147 156 (Pubitemid 23168529)
45. Tsafriri A, Reich R. Plasminogen activators in the preovulatory follicle: role in ovulation. In plasminogen activators: from cloning to therapy; 1991. Ed. Abbate, Raven Press. p. 81-93
46. M.S. Stack, S.M. Ellerbroek, and D.A. Fishman The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma Int J Oncol 12 1998 569 576 (Pubitemid 28097284)
47. S.A. Rabbani Mettaloproteinases and urokinase in angiogenesis and tumor progression In Vivo 12 1998 135 142 (Pubitemid 28177288)
48. H. Kobayashi, H. Ohi, M. Sugimura, H. Shionhara, T. Fugjii, and T. Terao Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B Can Res 52 1992 3610 3614
49. O. Wilhelm, M. Schmitt, S. Hohl, R. Senekowitsch, and H. Graeff Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice Clin Exp metast 13 1995 296 302
50. N. Auersperg, T. Ota, and G.W.E. Mitchell Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches Int J Gynecol Cancer 12 2002 691 703 (Pubitemid 35388036)
51. N. Auersperg, S.L. Maines-Bandiera, H.G. Dyck, and P.A. Kruk Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes Lab Invest 71 1994 510 518 (Pubitemid 24338158)
52. H.G. Dyck, T.C. Hamilton, A.K. Godwin, H.T. Lynch, S.L. Maines-Bandiera, and N. Auersperg Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer Int J Cancer 69 1996 429 436 (Pubitemid 27050516)
53. D. Huntsman, J.H. Reseau, E. Klineberg, and N. Auersperg Comparison of c-met expression in ovarian epithelial tumours and normal epithelia of the female reproductive tract by quantitative laser scan microscopy Am J Pathol 155 1999 343 348 (Pubitemid 29370384)
54. K.M. Feeley, and M. Wells Precursor lesions of ovarian epithelial malignancy Histopathology 38 2001 87 95 (Pubitemid 32193623)
55. D.W. Cramer, and W.R. Welch Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis J Natl Cancer Inst 71 1983 717 721 (Pubitemid 14232385)
56. D.M. Purdie, C.J. Bain, V. Siskind, P. Russell, N.F. Hacker, and B.G. Ward Hormone replacement therapy and risk of epithelial ovarian cancer Br J Cancer 81 1999 559 563 (Pubitemid 29458815)
57. L. Rosenberg, J.R. Palmer, A.G. Zauber, M.E. Warshauer, J.L. Lewis, and B.L. Strom A case-control study of oral contraceptive use and invasive epithelial ovarian cancer Am J Epidemiol 139 1994 654 661 (Pubitemid 24121274)
58. H.A. Rish Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone J Natl Cancer Inst 90 1998 1774 1786
59. G.M. Clinton, and W. Hua Estrogen action in human ovarian cancer Crit Rev Oncol Hematol 25 1997 1 9 (Pubitemid 27138045)
60. P.P. Garg, K. Kerlikowske, L. Subak, and D. Grady Hormone replacement therapy and the risk of epithelial ovarian cancer: A meta-analysis Obstet Gynecol 92 1998 472 479 (Pubitemid 28396879)
61. A. Green, D. Purdie, C. Bain, V. Siskind, P. Russell, and M. Quinn Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer Int J Cancer 71 1997 948 951 (Pubitemid 27252873)
62. D.W. Cramer, R.F. Liberman, L.T. Ernstoff, W.R. Welch, R. Greenberg, and B.L. Harlow Genital talc exposure and risk of ovarian cancer Int J Cancer 81 1999 351 356 (Pubitemid 29165192)
63. R.B. Ness, and C. Cottreau Possible role of ovarian epithelial inflammation in ovarian cancer J Natl Cancer Inst 92 2000 162 163 (Pubitemid 30089876)
64. P. Hardiman, J.J. Nieto, and A.B. McLean Infertility and ovarian cancer. Editorial Gyn Oncol 76 2000 1 2
65. T.S. Wan, L.C. Chan, H.Y. Ngan, and S.W. Tsao High frequency of telomeric associations in human ovarian surface epithelial cells transformed by HPV oncogenes Cancer Genet Cytogenet 95 1997 166 172
66. C.H. Lai, C.Y. Wang, C.Y. Lin, and C.C. Pao Detection of HPV RNA in ovarian and endometrial carcinomas by reverse transcription polymerase chain reaction Gynecol Obstet Invest 38 1994 276 280 (Pubitemid 24344500)
67. E. Savelieva, C.D. Belair, M.A. Newton, S. Devries, J.W. Gray, and F. Waldman 20q gain associates with immortalisation; 20q 13.2 amplification correlates with genome instability in HPV 16 E7 transformed human uro-epithelial cells Oncogene 14 1997 551 560 (Pubitemid 27090957)
68. M. Hoang-Ngoc, A. Smajda, M. Prade, and J.P. Sigalony Étude histologique de la gonade differentiation ovarienne au cours de l'organogense Arch Anat Pathol 37 1989 201 207 (Pubitemid 19277643)
69. J.S. Fleming, C.R. Beaufie, I. Haviv, G. Chenevix-Trench, and O.L. Tan Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses Mol Cell Endocrinol 247 2006 4 21 (Pubitemid 43277703)
70. L. Resta, S. Russo, G.A. Colucci, and J. Prat Morphologic precursors of ovarian epithelial tumours Obstet Gynecol 82 1993 181 186 (Pubitemid 23217655)
71. A. Berchuck, M.F. Kohler, M.P. Boente, G.C. Rodriguez, R.S. Whitaker, and R.C. Bast Growth regulation and transformation of ovarian epithelium Cancer 71 1993 545 551 (Pubitemid 23021249)
72. A.K. Folkins, E.A. Jarboe, A. Saleemuddin, Y. Lee, M.J. Callahan, and R. Drapkin A candidate precursor to pelvic serous cancer (p53 signature) an dits prevalence in ovaries and fallopian tubes from women with BRCA mutations Gynecol oncol 109 2008 168 173
73. C.P. Crum, R. Drapkin, D. Kindelberger, F. Medeiros, F. Miron, and Y. Lee Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer Clin Med Res 5 2007 35 44 (Pubitemid 350218778)
74. C.B. Powell, E. Kenley, L.M. Chen, B. Crawford, J. McLennan, and C. Zaloudek Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 2005 127 132 (Pubitemid 41702631)
75. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA 1 and BRCA 2 carriers Gynecol Oncol 100 2006 58 64 (Pubitemid 41815050)
76. M.J. Callahan, C.P. Crum, F. Medeiros, D.W. Kindelberger, J.A. Elvin, and J.E. Garber Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin oncol 25 2007 3985 3990 (Pubitemid 47477278)
77. K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, and P. Paley Pathologic findings in prophylactic oophorectomy specimens in high-risk women Gynecol oncol 87 2002 52 56 (Pubitemid 36027101)
78. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236 (Pubitemid 43740193)
79. C.P. Crum Intercepting pelvic cancer in the distal fallopian tube: theories and realities Mol Oncol 3 2009 165 170
80. C. Vaurs-Barriere, and F. Penault-Llorca Molecular abnormalities in epithelial ovarian tumours: present and future Bull Cancer 88 2001 741 751 (Pubitemid 32896843)
81. C.N. Landen, M.J. Birrer, and A.K. Sood Early events in the pathogenesis of epithelial ovarian cancer J Clin Oncol 26 2008 995 1005 (Pubitemid 351398093)
82. R.J. Kurman, and I. Ming-Shih Pathogenesis of ovarian cancer. Lessons from morphology and molecular biology and their clinical implications Int J Gynecol Pathol 27 2 2008 151 160 (Pubitemid 351450677)
83. I. Ming-Shih, and R.J. Kurman Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis Am J Pathol 164 2004 1511 1518 (Pubitemid 38529752)